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P Collin, T Reunala, E Pukkala, P Laippala, 0 Keyrilainen, A Pasternack Abstract The associated diseases in 335 coeliac patients diagnosed 1980-90 were compared with age and sex matched control patients with various gastrointestinal symptoms. Endocrine disorders were found in 11.9% of coeliac and 4.30/o of control patients (p=0.0003). Coeliac patients had insulin dependent diabetes mellitus significantly (p=0.0094) more often (5.40/o) than control patients (1.5%). Connective tissue diseases were found in 7.2% of coeliac and in 2.7% of control patients (p=0.011). Sj6gren's syndrome occurred in 3.30/0 of coeliac patients and in 0.3% of controls (p=0.0059). Autoimmune thyroid diseases were found in 5.40/0 and asthma in 3.6% of coeliac patients, but also in 2.7% and 3.6%, respectively, among control patients. The incidences of malignant diseases and the survival rate in coeliac patients were compared with those in the Finnish population. Ten coeliac patients developed a cancer during the follow up (mean 5.3 years, range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] but none had a lymphoma. The (Table I) . Of the total, 274 patients were diagnosed after clinical suspicion of coeliac disease, and 61 were detected by serological screening. The diagnosis of coeliac disease was based on the characteristic histological finding of subtotal or severe partial villous atrophy and crypt hyperplasia in small bowel biopsy.
All 335 patients were prescribed a gluten free diet and asked to attend a control examination after 6-12 months. Two hundred and seventy nine patients (83%) kept to the gluten free diet, 900/o of them adhering strictly according to two separate enquiries. Eighteen (6%) failed to maintain the diet at all, and 38 (1 1%) did not participate in the control examination. A control biopsy specimen during the gluten free diet was available from 258 coeliac patients. Mucosal recovery was seen in 90% of them. Twenty one patients maintaining the gluten free diet refused the control biopsy.
CONTROL PATIENTS
Control patients were selected from among outpatients subjected to upper gastrointestinal endoscopy at the Department of Medicine in 1980-90. They were age and sex matched with coeliac patients. Endoscopy of control patients had to take place within the same year as that in which the diagnosis of the corresponding coeliac patient was established. Abdominal pain or dyspepsia was the reason for endoscopic examination in 257 patients, thoracic pain or symptoms of gastro-oesophageal reflux in 45, and anaemia in 33. duodenum of these patients, and thus coeliac disease has been excluded.
ASSOCIATED DISEASES AND SURVIVAL DATA
The hospital records of all patients were examined thoroughly. From these a history of present and past diseases, diagnosed by general practitioners or in hospitals, was registered in the coeliac group at the time of diagnosis, and in the control group at the time of endoscopy. Associated diseases were similarly recorded during the follow up as long as data were available. The time of follow up included in the study was always the same for coeliac and the corresponding control patient. Because 102 (3 1%) of the control patients had been examined only once in hospital, the follow up data were based on 233 coeliac and respective control patients. The mean follow up time of these subjects was 3.1 years (range 05-1 years). The occurrence of malignant diseases and survival of coeliac patients were assessed up to the end of 1991. The follow up for cancer was made through the files of the Finnish Cancer Registry and for death through the Statistics Finland. The mean follow up time for malignant diseases and survival was 5-3 years (range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . The observed number of malignant diseases and survival was compared with those expected in the age and sex matched Finnish population.
STATISTICAL ANALYSIS Disease frequencies were compared by Fisher's exact test. The relative occurrence of malignant diseases was presented using standardised incidence ratios (SIR) with 95% confidence intervals. The five year survival of coeliac patients was compared with that in the Finnish population and the survival rates were displayed graphically.
Results

ENDOCRINE DISORDERS
Twelve per cent of the coeliac patients and 4.2% of the control patients were suffering from endocrine disorders (p=00003) ( Table III) . Insulin dependent diabetes mellitus was found in 5.4% of coeliac and 1-5% of control patients (p=0 0094). Eighteen (5.4%) coeliac patients and nine (2.7%) controls had autoimmune thyroid disease (autoimmune hypothyroidism or Graves' disease) (p=0. 11).
CONNECTIVE TISSUE DISEASES
Connective tissue diseases were found in 7.2% of coeliac patients and in 2-7% of controls (p=0.01 1). Sjogren's syndrome was diagnosed in 3.3% of coeliac patients and 0.3% of the control patients (p=00059), the diagnosis being defined according to the Californian criteria.9
Rheumatoid arthritis was found in 1.8% of coeliac and 2. 1% of the control patients.
OTHER DISEASES Asthma occurred in 3.6% of both coeliac and control patients; three of 12 such cases among coeliac patients were diagnosed during the follow up. Sarcoidosis was found in 1.5% of coeliac and none of the control patients (p=0062). Four coeliac patients had liver biopsy because of abnormal enzyme concentrations. One patient had primary biliary cirrhosis, one unspecific hepatitis, one cirrhosis of unknown aetiology, and one normal liver histology. No liver biopsy specimens were taken in the case of control patients.
Four coeliac patients and none of the controls had psoriasis (p=0.12). Fifteen (4.5%/o) coeliac patients were found to have dermatitis herpetiformis shortly after establishment of the diagnosis of coeliac disease. In one coeliac patient the rash developed during the follow up. MALIGNANT 
DISEASES
Malignancy had been found before the diagnosis of coeliac disease in four patients (Table IV) . In the control group, seven patients had a malignant disease before Coronary artery disease and in adults.'2 Two of our coeliac patients fl origin: a woman aged 50 years had Addison's disease, an association we have *cinoid tumour of the pancreas previously published.'3 Even though the the diagnosis of coeliac disease. number did not differ statistically significantly from that in the controls (p=0.50), the association could be real, because Addison's 'ATIENTS disease is very rare. The frequency of autofollow up, 11 (3.3%) coeliac immune thyroid diseases in this series was t men and three women, died. comparable with that in previously published vs the causes of death. The five studies (Table VII) . Nevertheless, the associa-*ate for men was 87.0% and for tion may be coincidental; the frequency did ' among coeliac patients. These not differ statistically significantly between did not differ statistically signifi-coeliac and control patients. ie rate in the general population There are earlier reports on the association between arthritis and coeliac disease.14 15 In this series, six coeliac patients and seven control patients had concomitant rheumatoid arthritis, which would suggest that rheumatoid arthritis is we found that 5.4% of coeliac not specifically associated with coeliac disease. nsulin dependent diabetes, 5.4% By contrast, there was a significant association thyroid disease, and 7.2% con-between coeliac disease and Sjogren's syndisease. The previously reported drome; 11 coeliac patients and only one control )f autoimmune diseases have patient had Sjogren's syndrome. There are few lower than those now found previous case reports of this association.16-18 In Cooper et al 3 examined 314 this study coeliac patients also had various other ts, a study almost equal in size to connective tissue diseases, albeit not in such nd insulin dependent diabetes in high numbers as Sjogren's syndrome. mune thyroid diseases in 3.2%, Patients with coeliac disease have an e tissue disease in 6. 1%.
increased frequency of HLA B8 and DR3 and tients had insulin dependent an almost 1 00% association has been seen with tus significantly more often than DQw2, which occurs in linkage disequilibrium ts. This may be due partly to the with DR3. The DQ alleles HLA DQA1*0501 abetic patients are frequently and DQB 1*0201 are evidently the most Logically for coeliac disease in our important disease susceptibility genes in association of coeliac disease and coeliac disease.'9 HLA B8 and DR3 can also ndent diabetes, however, has be found in insulin dependent diabetes mellin described both in children'0 11 tus,20 Addison 32 we found no increased frequency of epilepsy in our coeliac patients. The control subjects in this study were outpatients having gastrointestinal problems similar to those in symptomatic coeliac patients. This selection may increase the occurrence of diseases with gastrointestinal symptoms, for example rheumatoid arthritis and asthma. An increased risk of malignancy has been definitely established in coeliac disease; these patients are reported to have a 40 to 100-fold risk of developing non-Hodgkin's lymphoma.33 34 In this study none of the patients developed non-Hodgkin's lymphoma. The expected number of non-Hodgkin's lymphoma, however, was only 0-2 and the upper limit of the 95% confidence interval 3-6. The frequency of malignant diseases in coeliac patients did not differ significantly from that in the Finnish population in general. Holmes et al 34 showed that coeliac patients who have adhered to a strict gluten free diet for five years do not run an increased risk of malignancy; this implies that dietary treatment protects against the development of malignant disease. In their series of 210 coeliac patients, 22% did not have a gluten free diet. In this series, only 6% failed to adopt the prescribed diet and over 80% maintained it strictly. The comparatively low malignancy rate found in the present coeliac patients may thus be explained by good adherence to a gluten free diet.
Similarly, there was no statistically significant difference between the five year survival rate among coeliac patients and that in the population in general. By contrast, Logan et al 8 found a 1 9-fold death rate in coeliac patients in Scotland, attributable to the increased rate within five years after the diagnosis of coeliac disease.
In conclusion, this study showed that patients with coeliac disease have an increased prevalence of autoimmune diseases, especially of insulin dependent diabetes and Sjogren's syndrome. No increased rate of malignancy or death was seen in these patients.
